REVB icon

Revelation Biosciences (REVB)

NASDAQ

$1.21

$0.029 (

+2.41%

)

1D
5D
1M
6M
1Y
5Y
After hours

REVB: $1.21 / ₿ 0 BTC / 1772 Sats

1D
5D
1M
6M
1Y
5Y

Key statistics

$1.18
$1.06 - $44.77
$4.50M
2.38
$1.20
$42,792.84
3.72M
$1.15 - $1.23
$1.20 - $1.23
Yes

What is Revelation Biosciences (REVB)?

Revelation Biosciences Inc is a clinical-stage life science company focused on rebalancing inflammation to optimize health using its proprietary formulation, Gemini. The company is developing a pipeline of potential products based on Gemini, which is its proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD), a synthetic version of monophosphoryl lipid A (MPLA). PHAD is a small fragment of lipopolysaccharide (LPS) that stimulates TLR4 and leads to controlled production of multiple cytokines and chemokines that modulate the innate and adaptive immune response. The company operates through one reportable segment focused on the prevention and treatment of disease by developing and commercializing therapeutics that modulate the innate immune system.

The Revelation Biosciences (REVB) stock price has been rising

The Revelation Biosciences, Inc. Common Stock (REVB) stock after-hours price today is $1.21, reflecting a +2.41% after-hours move since the market last closed. The company’s market capitalization stands at $4.50M, with a daily trading volume of $42.79K shares. For investors tracking price trends, Revelation Biosciences, Inc. Common Stock stock has ranged between $1.20 and $1.23 today. The previous closing price was $1.18.

Get started with Revelation Biosciences (REVB)

Ready to get started? Follow the steps below, or read our guide on how to buy Revelation Biosciences stock on Kraken starting from $10.

Create an account

Create an account

Open the Kraken app to confirm your eligibility and follow the steps for account verification.



Deposit funds

Deposit funds

Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.

Buy

Buy REVB

Search for REVB in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy REVB.

REVB FAQs

REVB is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

REVB is in the Biotechnology industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

Over the past 52 weeks, Revelation Biosciences, Inc. Common Stock (REVB) has traded between a low of $1.06 and a high of $44.77.

REVB is in the Biotechnology industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

Want to invest in Revelation Biosciences? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free* - directly in the Kraken app. Download it and get started.

Fictional stock
USD icon
USD
REVB icon
REVB

Only available to USA clients through the Kraken app
or Kraken Pro.

Get the Kraken Pro app and buy Revelation Biosciences in minutes

Kraken App QR Code

Explore other stocks

Most active

Explore the most-traded stocks today

Top gainers

Browse today’s biggest stock market winners

LICYQ icon

LICYQ

BARK icon

BARK

UCAR icon

UCAR

Top losers

Compare the worst-performing stocks of 
the day

SDCCQ icon
YOTAR icon

YOTAR

BBIG icon

Want to learn more about equities?

Check out our Kraken Learn Center guides

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.

*Other applicable fees may apply.